BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 4977456)

  • 21. [The present status of prevention of Rh sensitization with anti-D sera].
    Preisler O; Schneider J
    Geburtshilfe Frauenheilkd; 1966 May; 26(5):732-4. PubMed ID: 4956775
    [No Abstract]   [Full Text] [Related]  

  • 22. [Effect in vivo of anti-D gamma globulin on Rh-positive fetal erythrocytes].
    Massi GB; Curiel P; Cattaneo A; Cesa F
    Boll Soc Ital Biol Sper; 1968 Nov; 44(22):1884-7. PubMed ID: 4186557
    [No Abstract]   [Full Text] [Related]  

  • 23. [Prevention of fetomaternal immunizations].
    Mahon R; Moulinier J; Dubecq JP; Lepage F; Ravina JH; Landeau MC
    J Gynecol Obstet Biol Reprod (Paris); 1972; 1():Suppl 1:3-50. PubMed ID: 4634195
    [No Abstract]   [Full Text] [Related]  

  • 24. [The Kleihauer test and directed prevention of hemolytic disease of the newborn due to materno-fetal Rh-factor isoimmunization. Preventive note].
    De Luca P; Adinolfi G; Corbo M
    Minerva Ginecol; 1980 Dec; 32(12):1179-81. PubMed ID: 6793940
    [No Abstract]   [Full Text] [Related]  

  • 25. [Immunoprophylaxis of neonatal hemolytic disease caused by Rh incompatibility. Analysis of a 5-year experience].
    Sansone G; Veneziano G; Mantegazza F; Cominetti M
    Pathologica; 1974; 66(961-962):477-89. PubMed ID: 4141760
    [No Abstract]   [Full Text] [Related]  

  • 26. [Prospects of the clinical use of immunosuppressive agents in control of materno-fetal Rh isoimmunization and in attempted prevention. (Theoretical presuppositions and preliminary clinical experiences)].
    Vecchietti G; Onnis A
    Minerva Ginecol; 1970 May; 22(9):459-62. PubMed ID: 4995415
    [No Abstract]   [Full Text] [Related]  

  • 27. [Prevention with gamma globulin of Rh isoimmunization: current problems. Review].
    Spensieri S; Carnevale-Arella E
    Riv Ostet Ginecol; 1968 Nov; 23(11):792-800. PubMed ID: 4187892
    [No Abstract]   [Full Text] [Related]  

  • 28. Clinical experience with a new preparation of Rh 0 (D) immune globulin (human).
    Wurzel JF; Hansen LM; Evensen KL
    Obstet Gynecol; 1973 May; 41(5):760-4. PubMed ID: 4633212
    [No Abstract]   [Full Text] [Related]  

  • 29. [Therapy and prevention of hemolytic disease of the newborn caused by the Rh factor].
    Kogoj-Bakic V
    Lijec Vjesn; 1970 Nov; 92(11):1323-31. PubMed ID: 4332439
    [No Abstract]   [Full Text] [Related]  

  • 30. [The rhesus problem today].
    Schneider J; Behrens O
    Gynakologe; 1992 Feb; 25(1):36-40. PubMed ID: 1547980
    [No Abstract]   [Full Text] [Related]  

  • 31. [The signifince of Rh incompatibility for the obstetrician].
    Heiss H
    Wien Med Wochenschr; 1965 Nov; 115(45):941-5. PubMed ID: 4957662
    [No Abstract]   [Full Text] [Related]  

  • 32. Rh hemolytic disease of the newborn: its cause and prevention.
    Pollack W
    Prog Clin Biol Res; 1981; 70():185-302. PubMed ID: 6273932
    [No Abstract]   [Full Text] [Related]  

  • 33. Standarization of anti-D for use in the prevention of Rh sensitization.
    Hughes-Jones NC
    Prog Immunobiol Stand; 1970; 4():279-81. PubMed ID: 4992311
    [No Abstract]   [Full Text] [Related]  

  • 34. [Practical problems of preventing Rh sensitization using immunological methods].
    Althoff W; Schellong G; Stahl M
    Rev Clin Esp; 1969 Sep; 114(6):515-24. PubMed ID: 4988856
    [No Abstract]   [Full Text] [Related]  

  • 35. [Problems in anti-rhesus (D) immunoprophylaxis].
    Bennebroek Gravenhorst J; Overbeeke MA; van Dijk BA
    Ned Tijdschr Geneeskd; 1984 May; 128(21):1005-9. PubMed ID: 6429554
    [No Abstract]   [Full Text] [Related]  

  • 36. [Immunosuppressive mechanism and effect of immunoglobulins Anti D and Anti DK (IgG) in the prevention of hemolytic disease of the newborn caused by Rh incompatibility].
    Skrzypulec ZA
    Zentralbl Gynakol; 1973 Mar; 95(12):402-10. PubMed ID: 4634158
    [No Abstract]   [Full Text] [Related]  

  • 37. The importance of antibody concentration, binding constant, and antibody heterogeneity in the suppression of immunity to the Rh factor.
    Pollack W
    Ann Ostet Ginecol Med Perinat; 1970 Jul; 92(7):415-21. PubMed ID: 4110458
    [No Abstract]   [Full Text] [Related]  

  • 38. [10 years of specific prophylaxis of hemolytic disease of the newborn in Bulgaria].
    Kurteva B; Doĭchinova N; Shinkov D; Angelova Ts; Ivanova L
    Akush Ginekol (Sofiia); 1979; 18(3):172-9. PubMed ID: 89820
    [No Abstract]   [Full Text] [Related]  

  • 39. [Current value of the Kleihauer test apropos of the prevention of fetomaternal isoimmunization].
    Carrière M; Battaglini PF; Nublat M; Serment H
    Bull Fed Soc Gynecol Obstet Lang Fr; 1970; 22(1):69-76. PubMed ID: 4989262
    [No Abstract]   [Full Text] [Related]  

  • 40. [Is the prevention of sensitization of rhesus negative women possible?].
    Schneider J
    Landarzt; 1968 Mar; 44(9):443-6. PubMed ID: 4180650
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.